EMC China Lab

What Biocompatibility Testing is Required for Clinical Trials?

Views :
Update time : 2024-06-08

The purpose of biocompatibility testing is to ensure that materials do not release toxic substances when they come into contact with the human body, thereby preventing local or systemic cytotoxicity, carcinogenicity, and reproductive toxicity. Additionally, materials should not cause inflammatory reactions, immune responses, toxic reactions, or thrombosis formation upon contact with the human body.

 

What Biocompatibility Testing is Required for Clinical Trials?(图1)

Classification of Medical Devices Based on Risk (FDA Guidelines)

The regulation of medical devices primarily references the US FDA guidelines, classifying devices based on risk levels:

- Class I: Low risk

- Class II: Medium risk

- Class III: High risk

 

Only Class III and some Class II products require preclinical trials before market release, providing relevant data and literature. Below are the biocompatibility tests required for clinical trials of medical devices:

 

Biocompatibility Test Items for Medical Devices According to ISO 10993-1:2018

cytotoxicity test  

When cells are stimulated by toxic substances, they may exhibit morphological changes, vacuolization, detachment, cell lysis, changes in cell membrane integrity, and even cell death. The MTT assay involves living cells converting yellow MTT into blue formazan crystals within the mitochondrial respiratory chain, detected by absorbance to determine cell viability.

 

Skin Sensitisation Test  

Evaluates if medical devices or substances cause contact allergies and delayed-type hypersensitivity (Type IV). The most sensitive sensitization test involves mixing an adjuvant with the test extract and injecting it intradermally into guinea pigs, observing potential allergenic reactions.

- Test methods: Maximization Sensitisation Test, Closed Patch Test

- Reference standards: iso 10993-10, OECD #406

 

Skin Irritation Test  

Assesses whether medical devices or substance components cause skin irritation. Test substances, either directly or through extracts, are applied to rabbit skin, observing potential irritation.

- Reference standards: ISO 10993-23, OECD #404

 

Intracutaneous Irritation Test  

Evaluates whether components of medical devices cause intracutaneous irritation. Extracts of test substances are injected intradermally into rabbits, observing potential irritation.

- Reference standards: ISO 10993-23

 

Eye Irritation Test  

Assesses whether components of medical devices cause ocular irritation. Extracts of test substances are instilled into rabbit eyes, observing potential irritation to the cornea, conjunctiva, and iris.

- Reference standards: ISO 10993-23, OECD #405

 

Acute Systemic Toxicity Test  

Evaluates the potential hazardous effects of medical devices or substances through single short-term exposure to the test animals.

- Reference standards: ISO 10993-11

 

Pyrogen Test  

Assesses whether components of medical devices contain pyrogens. Extracts of test substances are injected into rabbit ear veins, observing changes in body temperature.

- Reference standards: USP 151

 

Endotoxin Test  

Endotoxins, toxins produced by Gram-negative bacteria, are common pyrogens causing febrile reactions. Turbidimetric and chromogenic methods measure endotoxin levels. Turbidimetric reagents cause coagulation in the presence of endotoxins, while chromogenic reagents produce a yellow reaction through Boc-Leu-Gly-Arg-pNA cleavage, calculating concentration using a standard curve.

 

Implantation Test  

Evaluates whether components of medical devices cause local reactions. Test substances are implanted in appropriate locations within rabbit bodies (subcutaneous, muscle, bone), observing clinical physiological conditions and histopathological analysis.

- Reference standards: ISO 10993-6

 

What Biocompatibility Testing is Required for Clinical Trials?(图2)

What Biocompatibility Testing is Required for Clinical Trials?(图3)

Hemolysis Test  

Hemolysis is the release of hemoglobin from damaged or partially damaged red blood cells. In vitro tests assess red blood cell damage:

- Direct contact method: Detects hemolysis caused by physical forces or chemical interactions.

- Extraction method: Detects hemolysis caused by test substance extracts using commercially available hemoglobin detection kits.


Email:hello@jjrlab.com


Leave Your Message


Write your message here and send it to us


Related News
Read More >>
Laser Product Qualification Consultants Laser Product Qualification Consultants
04 .27.2025
JJR Test LAB offers laser product qualification testing based on EN 50689:2021, ensuring safety for ...
UL 268 Smoke Detector UL 268 Smoke Detector
04 .27.2025
The US recalls faulty smoke detectors. Ensure compliance with UL 217, UL 268, and UL 2034. JJR Lab p...
How to Get Approved to Sell Toys on Amazon How to Get Approved to Sell Toys on Amazon
04 .27.2025
To sell toys on Amazon, products must meet CPC, EN71, ASTM F963, and ST Mark standards. JJR Lab Chin...
Element EMC Testing Element EMC Testing
04 .27.2025
China JJR Laboratory offers element EMC testing, ensuring components meet EMI/EMS standards for reli...
Authorized Representative EU Authorized Representative EU
04 .27.2025
EU Authorized Rep ensures CE compliance for EEA markets. China JJR Lab offers testing and one-stop s...
EU Representative Service EU Representative Service
04 .27.2025
JJR Lab offers EU Representative services to help manufacturers comply with (EU) 2019/1020 for marke...
ASTM F2413 Shoes Certification Testing ASTM F2413 Shoes Certification Testing
04 .27.2025
China JJR Laboratory offers ASTM F2413 footwear testing, ensuring compliance with U.S. standards for...
UL Listed Smoke and CO Detectors UL Listed Smoke and CO Detectors
04 .27.2025
UL listed smoke and CO detectors must meet US/Canada standards (UL 217, UL 268, CAN/ULC-S531). China...

Leave Your Message